secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0000947871-26-000244
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics elects former Walgreens CEO Timothy Wentworth to board
------------------------------------------------------------------------

- Elected Timothy Wentworth, former CEO of Walgreens Boots Alliance, as director effective March 9, 2026.
- Appointed to Compensation and Leadership Development and Quality and Compliance Committees.
- Received prorated restricted share unit grant valued at approximately $43,000 upon joining board.
- Board now consists of 11 members including Wentworth.
- Wentworth also previously CEO of Evernorth Health Services and Express Scripts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000094787126000244/0000947871-26-000244-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000094787126000244/ss6056588_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-26-000244

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer